Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has John K. Maesaka's publication output changed over time?
ScholarIQpublication output · 1975–2002
Output grew0% over the shown period — from 1 works in 1975 to 1 in 2002.
1
1
1
2
2
1
1
1
19751983199519961997199920012002
What are the most-cited papers on John K. Maesaka?
ScholarIQmost cited works
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
Steven Fishbane, Gill L. Frei, John K. Maesaka
American Journal of Kidney Diseases. 1995377 CitationsOPEN ACCESS
Cerebral Salt-Wasting Syndrome: Does It Exist?
John K. Maesaka, Sandeep Gupta, Steven Fishbane
The Nephron journals/Nephron journals. 1999338 Citations
A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography
John D. Durham, Christopher Caputo, John Dokko, Thomas Zaharakis, Mohsen Pahlavan, Jan M Keltz, Paula Dutka, Kevin Marzo, John K. Maesaka, Steven Fishbane
Kidney International. 2002301 CitationsOPEN ACCESS
The safety of intravenous iron dextran in hemodialysis patients
Steven Fishbane, Virgiliu-Dan Ungureanu, John K. Maesaka, Charles J. Kaupke, Victoria S. Lim, Jay B. Wish
American Journal of Kidney Diseases. 1996274 Citations
Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients
Steven Fishbane, Cynthia Galgano, Robert C. Langley, William M. Canfield, John K. Maesaka
Kidney International. 1997219 CitationsOPEN ACCESS
Related on ScholarIQ
Long Island University
Institution
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
Paper
Cerebral Salt-Wasting Syndrome: Does It Exist?
Paper
A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography
Paper
The safety of intravenous iron dextran in hemodialysis patients
Paper
Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients
Paper